The pharmacotherapy of migraine
- PMID: 2867457
- DOI: 10.5694/j.1326-5377.1986.tb113667.x
The pharmacotherapy of migraine
Abstract
The relative importance of neural and humoral components in the pathogenesis of migraine has yet to be determined, but there is circumstantial evidence that implicates noradrenaline and serotonin as neural or humoral mediators in the recurrent headache, neurological and gastrointestinal symptoms that comprise the migraine syndrome. The treatment of migraine includes the avoidance of precipitating factors when possible, psychological counselling and relaxation training. Pharmacotherapy can be considered rationally in terms of agents acting on receptors that may possibly play a part in the mechanism of migraine.
Similar articles
-
Migraine. Current concepts of pathogenesis and treatment.Drugs. 1983 Oct;26(4):364-71. doi: 10.2165/00003495-198326040-00006. Drugs. 1983. PMID: 6414797 No abstract available.
-
Migraine.CMAJ. 1988 Jan 15;138(2):107-13. CMAJ. 1988. PMID: 2891428 Free PMC article. Review.
-
[Antimigrainous agents used in maintenance treatment].Rev Prat. 1986 Jan 21;36(5):199-204. Rev Prat. 1986. PMID: 2870558 French. No abstract available.
-
Treatment of migraine and cluster headache.Panminerva Med. 1982 Apr-Jun;24(2):85-7. Panminerva Med. 1982. PMID: 7145460 No abstract available.
-
The pharmacology of medications used in treating headache.Semin Pediatr Neurol. 1995 Jun;2(2):165-77. doi: 10.1016/s1071-9091(05)80027-0. Semin Pediatr Neurol. 1995. PMID: 9422244 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical